Bicycle Therapeutics plc

IPO

Home - Bicycle Therapeutics

Public · Cambridge, United Kingdom · $52.0M raised

Headquarters
Cambridge
Employees
51–200
Business Model
B2B
Total Funding
$52.0M
Last Round
$52.0M Series BJun 2017
Rounds
1
Type
Public

About

Clinical-stage biopharmaceutical company developing precision-guided therapeutics using bicyclic peptides to target intractable cancers and other serious diseases.

Summary

Bicycle Therapeutics plc is a Biotech company based in Cambridge, United Kingdom. It has raised $52.0M in total across 1 round, most recently a $52.0M Series B round in Jun 2017. Investors include Deep Track Capital, EcoR1 Capital and Fairmount.

Tech & App Stack

4 technologies & apps tracked

Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Secondary MarketSecondary MarketJun 2024
$555.0M

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies